A detailed history of Richard C. Young & Co., Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Richard C. Young & Co., Ltd. holds 439,189 shares of PFE stock, worth $12.4 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
439,189
Previous 417,506 5.19%
Holding current value
$12.4 Million
Previous $11.6 Million 6.07%
% of portfolio
1.58%
Previous 1.54%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $547,712 - $641,816
21,683 Added 5.19%
439,189 $12.3 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $5.8 Million - $6.66 Million
224,125 Added 115.9%
417,506 $11.6 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $5.19 Million - $6.74 Million
-198,456 Reduced 50.65%
193,381 $5.57 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $68,191 - $79,708
2,125 Added 0.55%
391,837 $13 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $286,828 - $331,854
7,941 Added 2.08%
389,712 $14.3 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $72,398 - $94,252
-1,838 Reduced 0.48%
381,771 $15.6 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $62,792 - $81,968
-1,504 Reduced 0.39%
383,609 $19.7 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $14,965 - $18,269
342 Added 0.09%
385,113 $16.9 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $217,574 - $257,974
4,676 Added 1.23%
384,771 $20.2 Million
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $323,727 - $401,138
-7,076 Reduced 1.83%
380,095 $19.7 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $233,953 - $346,797
5,662 Added 1.48%
387,171 $22.9 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $60,013 - $77,092
-1,529 Reduced 0.4%
381,509 $16.4 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $389,228 - $440,930
10,839 Added 2.91%
383,038 $15 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $838,824 - $946,025
25,047 Added 7.21%
372,199 $13.5 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $450,773 - $573,198
13,468 Added 4.04%
347,152 $12.8 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $3.69 Million - $4.33 Million
116,241 Added 53.46%
333,684 $12.2 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $23,343 - $28,318
-775 Reduced 0.36%
217,443 $7.11 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $577,901 - $825,695
21,380 Added 10.86%
218,218 $7.12 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $3.38 Million - $3.83 Million
102,575 Added 108.82%
196,838 $7.71 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $3.31 Million - $4.29 Million
-101,918 Reduced 51.95%
94,263 $3.39 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $89,380 - $100,353
2,417 Added 1.25%
196,181 $8.5 Million
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $7.27 Million - $7.98 Million
193,764 New
193,764 $8.23 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Richard C. Young & Co., Ltd. Portfolio

Follow Richard C. Young & Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard C. Young & Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Richard C. Young & Co., Ltd. with notifications on news.